North America Urinalysis Market, By Testing Type (Urine Biochemistry Testing, Urine Biochemistry Testing), Product (Instruments, Consumables), Test Type (Biochemical, Pregnancy and Fertility, Sediment), Modality (Portable, Standalone, Table Top, Bench Top, Others), Application (Disease Screening, Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility, Others), End User (Hospital, Laboratory, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
North America Urinalysis Market Analysis and Size
According to the National Diabetes Statistics Report, 2020, approximately 34.2 million people aged 18 and up in the United States have diabetes. One-third of diabetics have kidney-related comorbidities as a result of high blood sugar and blood pressure. Urinalysis is a non-invasive and informative diagnostic tool that clinicians can use to diagnose kidney disease. As a result, the rising prevalence of kidney diseases is expected to increase demand for urinalysis products, driving market growth.
Data Bridge Market Research analyses that the urinalysis market which was USD 1522.23 million in 2022, would be up to USD 2481.68 million by 2030, and is expected to undergo a CAGR of 6.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Urinalysis Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Testing Type (Urine Biochemistry Testing, Urine Biochemistry Testing), Product (Instruments, Consumables), Modality (Portable, Standalone, Table Top, Bench Top, Others), Application (Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility, Others), End User (Hospital, Laboratory, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail Sales) |
Countries Covered |
U.S., Canada and Mexico in North America |
Market Players Covered |
Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (U.S.), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Quidel Corporation (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), EKF Diagnostics (U.K.), Thermo Fisher Scientific Inc. (U.S.), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (U.K.), Alphatech Scientitfic E.I.R.L (Peru), Teco Diagnostics (U.S.), Analyticon Biotechnologies GmbH (Germany) |
Market Opportunities |
|
Market Definition
A urine analysis is a test that is carried out to examine the pee. A urine test can be used to help diagnose diseases because the body excretes toxins and extra fluid in the form of urine. A urine analysis can be used to diagnose renal disease and other illnesses. It involves performing a clinical analysis of urine tests to look for certain physical characteristics including solutes, cells, casts, crystals, organisms, or particle debris.
Urinalysis Market Dynamics
Drivers
- Increase in age-associated diseases
The ageing population in both developed and developing countries will benefit the urinalysis market. The prevalence of age-related illnesses such as diabetes, liver and kidney disease is expected to rise dramatically as the senior population grows rapidly. The diagnosis and treatment of such conditions has resulted in increased prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin, among others. This market is expected to benefit because urinalysis is used to perform these tests.
- Rising geriatric population
The growing geriatric population in both developed and developing countries is driving the global urinalysis market. Furthermore, the market is expanding as a result of the adoption of point-of-care diagnostics and the rising prevalence of chronic diseases. Furthermore, the desk-bound lifestyle of working people leads to a general lack of good health among the populace in many areas, fuelling demand for better diagnostics such as urinalysis. As a result, the growing demand for routine health checks is a driving factor in the market's growth.
Opportunities
- Rise in significant investments
The high disease prevalence, expanding medical tourism, sizable patient population, improving healthcare infrastructure, and rising disposable income in these nations. The majority of players are turning their attention to emerging regions. Upgrading laboratory infrastructure in emerging markets is crucially dependent on the significant investments made in healthcare and life sciences research in these nations. As a result, the market for urinalysis expands and encourages the installation of diagnostic equipment in laboratories.
Restraints/Challenges
- Unfavourable reimbursement scenario
The rise of this industry is threatened by the accessibility of refurbished instruments, which perform the same tasks as new equipment at a lower cost. The economy's use of used items could rise as a result of weak regulatory systems.
- High Cost
Factors affecting the urinalysis market from growing are the high equipment cost and stringent government regulations.
This urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Urinalysis Market
With the COVID-19 pandemic, there is an increased need for the development of testing infrastructures, vaccines, and therapeutic drugs as well as more precise and user-friendly testing technology. Because COVID-19 altered the regulatory landscape and processes, governments and healthcare providers are now dealing with previously unheard-of problems. Regulatory agencies employed strategies to hasten the approval of diagnostic products. Businesses have advanced strategically to implement COVID-19 rapid testing, sustain their revenues, and mitigate the impact of COVID-19 on their operational capabilities.
Recent Development
- In 2020, DIRUI announced the signing of an agreement to build a laboratory for high-quality IVD product manufacturing in collaboration with Changchun Center Hospital. This decision aided in the implications of the testing process, reduced repeated examinations, and reduced the cost of diagnosis. This will result in significant growth for the company over time.
North America Urinalysis Market Scope
The urinalysis market is segmented on the basis of testing type, product, modality, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Testing Type
- Urine Biochemistry Testing
- Urine Biochemistry Testing
Product
- Instruments
- Biochemical Urine Analyzers
- Automated biochemical analyzers
- Semi-automated Biochemical Analyzers
- Automated Urine Sediment Analyzers
- Microscopic Urine Analyzers
- Flow-Cytometric Urine Analyzers
- Point-Of-Care Urine Analyzers
- Consumables
- Dipsticks
- Reagents
- Disposables
- Pregnancy and Fertility Kits
Modality
- Portable
- Standalone
- Table Top
- Bench Top
- Others
Application
- Urinary Tract Infections
- Kidney Diseases
- Diabetes
- Liver Diseases
- Pregnancy and Fertility
- Others
End User
- Hospital
- Laboratory
- Home Care Settings
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Urinalysis Market Regional Analysis/Insights
The urinalysis market is analyzed and market size insights and trends are provided by country, testing type, product, modality, application and end-user as referenced above.
The countries covered in the urinalysis market report are U.S., Canada and Mexico in North America.
U.S. is expected to dominate the market as the number of urinalysis has increased in recent years as a result of the increasing high adoption of urinalysis for the treatment of liver disease and urinary tract infections. As the number of urinalysis patients in the United States continues to rise, the United States is expected to dominate the market and lead growth in the North American market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Urinalysis Market Share Analysis
The urinalysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinalysis market.
Some of the major players operating in the urinalysis market are:
- Siemens (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Cardinal Health (U.S.)
- Abbott (U.S.)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Quidel Corporation (U.S.)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- EKF Diagnostics (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- ACON Laboratories, Inc. (U.S.)
- 77 Elektronika Kft. (Hungary)
- URIT Medical Electronic Group Co., Ltd. (China)
- Dirui Industrial Co., Ltd. (China)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- BIOBASE Group (China)
- ERBA Mannheim (U.K.)
- Alphatech Scientitfic E.I.R.L (Peru)
- Teco Diagnostics (U.S.)
- Analyticon Biotechnologies GmbH (Germany)
SKU-